Concord Drugs Ltd
₹0.00▲ +0.00 (+0.00%)
538965·NSE·Healthcare
Market Cap
96.16 Cr
PE Ratio
88.80
Volume
—
Day High - Low
—
52W High-Low
92.52 - 49.00
₹0.00▲ +0.00 (+0.00%)
Market Cap96.16 Cr
PE Ratio88.80
Volume—
Day High - Low—
52W High-Low92.52 - 49.00
Concord Drugs Ltd (538965): company summary
Concord Drugs Ltd (538965) is a micro-cap Healthcare company valued at ₹96 crore operating in Pharmaceuticals on the NSE and BSE.
Concord Drugs Ltd (538965) is a micro-cap Healthcare company valued at ₹96 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 15.3% a year over three years; profit grew 5.7% a year, behind revenue — margins are under pressure. Return on equity is 2.5%.
- Valuation multiples
- The stock trades at 88.8 times earnings, a premium to the Healthcare median of 32.5, 1.93 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
1.9/10
Poor
Fair Value
Sign in to see
ROE
2.52%
Weak
P/E
88.80x
Expensive
Debt / Equity
0.24
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
52W₹49.00
₹92.52
DocStoX take
Held back by valuation (0.0). Scored on 4 of 5 measures.
DocStoX score
Medium confidence1.9
/10
Poor
Quality
Weak
ROE 2.5%
Valuation
Expensive
P/E 88.8×
Growth
Flat
Revenue +8.9% 5Y CAGR
Risk
Elevated
D/E 0.24
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹96 Cr
52W High / Low
₹93 / ₹49
Dividend Yield
0.00%
Promoter Holding
45.08%
EPS (TTM)
₹0.30
Book Value
₹36.82
Key highlights
- Low leverage — D/E 0.24
- Profitable in all of the last 5 years
- Profit shrinking 20% a year
- Quality is weak (2.2/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Concord Drugs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Concord Drugs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Concord Drugs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing